Literature DB >> 32217291

Lung clearance index evaluation in detecting nocturnal hypoxemia in cystic fibrosis patients: Toward a new diagnostic tool.

Maria Papale1, G F Parisi1, L Spicuzza1, A Licari2, A Bongiovanni1, E Mulè1, N Rotolo1, S Manti3, S Leonardi1.   

Abstract

BACKGROUND: Nocturnal hypoxemia adversely affects outcomes in patients with cystic fibrosis (CF). Although an early detection of this abnormality may be desirable, still its predictability remains uncertain. The Lung Clearance Index (LCI) is a measure of lung ventilation distribution obtained from a multiple-breath washout technique (MBW), recently implemented in patients with CF. This study aimed to establish whether the LCI predicts nocturnal hypoxemia in patients with stable CF, with mild to moderate disease, and normal diurnal gas exchange.
METHODS: 31 stable patients (15 males, mean age 17.4 ± 5.2 years) with mild to moderate CF, normoxic when awake, were enrolled. In all patients we performed nocturnal cardio-respiratory polygraphy, lung function measurement, and MBW test to derive LCI values.
RESULTS: LCI was abnormal in most of the patients and inversely correlated with mean nocturnal SpO2 (r = -0.880 p < 0.01). A receiver operating characteristic (ROC) analysis, performed to assess whether LCI predicted nocturnal hypoxemia, revealed a high predictive accuracy of LCI for nocturnal desaturation (AUC = 0.96; Youden index = 0.79). Forced expiratory volume in 1 s (FEV1) was predictive only in patients with more severe airway obstruction, with a moderate degree of accuracy (AUC 0.71).
CONCLUSIONS: The LCI showed a high effectiveness in predicting nocturnal hypoxemia in stable patients with CF, particularly when compared with a traditional parameter of lung function such as FEV1.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cystic fibrosis; Lung clearance index; Lung function test; Nocturnal hypoxemia

Year:  2020        PMID: 32217291     DOI: 10.1016/j.rmed.2020.105906

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  3 in total

1.  Nocturnal non invasive ventilation in normocapnic cystic fibrosis patients: a pilot study.

Authors:  Maria Papale; Giuseppe Parisi; Lucia Spicuzza; Novella Rotolo; Enza Mulè; Donatella Aloisio; Sara Manti; Salvatore Leonardi
Journal:  Acta Biomed       Date:  2021-05-12

Review 2.  Toward the Establishment of New Clinical Endpoints for Cystic Fibrosis: The Role of Lung Clearance Index and Cardiopulmonary Exercise Testing.

Authors:  Elpis Hatziagorou; Asterios Kampouras; Vasiliki Avramidou; Ilektra Toulia; Elisavet-Anna Chrysochoou; Maria Galogavrou; Fotios Kirvassilis; John Tsanakas
Journal:  Front Pediatr       Date:  2021-02-25       Impact factor: 3.418

Review 3.  Focus on gastroesophageal reflux disease in patients with cystic fibrosis.

Authors:  Annarita Bongiovanni; Sara Manti; Giuseppe Fabio Parisi; Maria Papale; Enza Mulè; Novella Rotolo; Salvatore Leonardi
Journal:  World J Gastroenterol       Date:  2020-11-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.